Yazdan Yazdanpanah
Expertise in
11
conditions

Yazdan Yazdanpanah

Paris, FR 
Expertise in
11
conditions
Paris, FR 

Overview

Yazdan Yazdanpanah practices in Paris, France. Dr. Yazdanpanah is highly rated in 11 conditions, according to our data. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Heart Transplant.

His clinical research consists of co-authoring 404 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Paris, 75018, France
Other Locations
Saint-claude-de-diray, France
Lille, France
France
Tourcoing, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Enrollment Status: Completed
Publish Date: November 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase IIIb, Open-label, Hybrid Type III Trial Evaluating Implementation Strategies for Long-acting Cabotegravir Plus Long-acting Rilpivirine Every Two Months in HIV-1 Infected, Virologically Suppressed Adults in Select European Healthcare Settings
A Phase IIIb, Open-label, Hybrid Type III Trial Evaluating Implementation Strategies for Long-acting Cabotegravir Plus Long-acting Rilpivirine Every Two Months in HIV-1 Infected, Virologically Suppressed Adults in Select European Healthcare Settings
Enrollment Status: Completed
Publish Date: April 05, 2024
Intervention Type: Drug, Other
Study Drug: Cabotegravir
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
Prevention of HIV in Île-de-France
Prevention of HIV in Île-de-France
Enrollment Status: Unknown
Publish Date: June 02, 2022
Intervention Type: Drug
Study Phase: Not Applicable
A Randomized, Double-Blind (Sponsor-unblinded), Placebo-Controlled, Adaptive Trial to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK3640254 in HIV-1 Infected Treatment-Naïve Adults
A Randomized, Double-Blind (Sponsor-unblinded), Placebo-Controlled, Adaptive Trial to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK3640254 in HIV-1 Infected Treatment-Naïve Adults
Enrollment Status: Completed
Publish Date: February 16, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

401 Total Publications

Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis.
Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 22, 2026

Frequently Asked Questions about Yazdan Yazdanpanah

Is Yazdan Yazdanpanah a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Yazdan Yazdanpanah is classified as an Elite expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yazdan Yazdanpanah participate in research or clinical trials?

Yes. Yazdan Yazdanpanah has published 401 articles and abstracts on conditions like HIV/AIDS. You can view a list of Yazdan Yazdanpanah's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yazdanpanah's expertise for a condition
ConditionClose
View All 38 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile